SUMMA RX LABORATORIES INC
10KSB40, EX-27, 2000-09-26
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10KSB40, EX-23, 2000-09-26
Next: LINCOLN LIFE FLEXIBLE PREMIUM VARIABLE LIFE ACCOUNT D, N-30D, 2000-09-26



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-KSB
FOR THE YEAR ENDED APRIL 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE
TO SUCH FORM 10-KSB FOR THE YEAR ENDED APRIL 30, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          APR-30-2000
<PERIOD-START>                             MAY-01-1999
<PERIOD-END>                               APR-30-2000
<CASH>                                       1,352,751
<SECURITIES>                                         0
<RECEIVABLES>                                  679,242
<ALLOWANCES>                                   124,569
<INVENTORY>                                    262,919
<CURRENT-ASSETS>                             2,250,719
<PP&E>                                       1,642,111
<DEPRECIATION>                                 741,463
<TOTAL-ASSETS>                               3,535,938
<CURRENT-LIABILITIES>                          905,351
<BONDS>                                        380,000
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                   2,219,129
<TOTAL-LIABILITY-AND-EQUITY>                 3,535,938
<SALES>                                      4,445,461
<TOTAL-REVENUES>                             6,033,299
<CGS>                                        3,381,385
<TOTAL-COSTS>                                4,292,702
<OTHER-EXPENSES>                                23,316
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              62,913
<INCOME-PRETAX>                                113,162
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            113,162
<DISCONTINUED>                                       0
<EXTRAORDINARY>                              1,587,838
<CHANGES>                                            0
<NET-INCOME>                                 1,701,000
<EPS-BASIC>                                        .54
<EPS-DILUTED>                                      .54


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission